January 31, 2024 US FDA warns consumers over copycats of Bausch + Lomb eye drops The U.S. Food and Drug Administration (FDA) on Wednesday warned consumers not to use unapproved eye drops that ...

Shares in ophthalmology specialist Bausch + Lomb (B+L) have lost almost 10% of ... intraocular lenses, and eye surgery products, and made revenues of $4.15 billion last year.

As a fully integrated eye health business, Bausch + Lomb has an established line of contact lenses, intraocular lenses (“IOLs”) and other medical devices, surgical systems and devices ...

Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care ...

2025--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its fourth-quarter and ...

Bausch + Lomb Corporation (NYSE:BLCO; TSX:BLCO), a prominent player in the global eye health market with a market capitalization of $5.78 billion, has been navigating a complex landscape of ...